An Overview of High-Efficacy Drugs for Multiple Sclerosis: Gulf Region Expert Opinion

This article discusses the opinions of the multiple sclerosis (MS) experts in the Gulf region on the use of high-efficacy disease-modifying drugs (DMDs; natalizumab, fingolimod, alemtuzumab, cladribine tablets, and ocrelizumab) in clinical practice. The experts reviewed the current literature includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Alroughani, Raed, Inshasi, Jihad Said, Deleu, Dirk, Al-Hashel, Jasem, Shakra, Mustafa, Elalamy, Osama Robin, Shatila, Ahmed Osman, Al-Asmi, Abdullah, Al Sharoqi, Isa, Canibano, Beatriz Garcia, Boshra, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534637/
https://www.ncbi.nlm.nih.gov/pubmed/30875021
http://dx.doi.org/10.1007/s40120-019-0129-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534637/
https://www.ncbi.nlm.nih.gov/pubmed/30875021
http://dx.doi.org/10.1007/s40120-019-0129-0

Ejemplares similares